Actively Recruiting
A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis
Led by Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Updated on 2025-06-22
380
Participants Needed
1
Research Sites
187 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is being conducted to evaluate the efficacy and safety of SHR-1314 injection in adult patients with active non-radiographic axial spondyloarthritis.
CONDITIONS
Official Title
A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older at the time of signing informed consent, any gender
- Body Mass Index (BMI) of 18 kg/m² or higher at screening
- Presence of objective signs of inflammation at screening
- Voluntarily signed informed consent form before any study procedures
- Ability to communicate effectively and willingness to follow study protocol
You will not qualify if you...
- Active systemic or severe infection
- Active tuberculosis or latent tuberculosis infection
- Lymphoma or lymphoproliferative disease
- Uncontrolled hypertension
- History of malignancy within past 5 years or current malignancy
- Moderate to severe congestive heart failure
- History of organ transplantation or severe, progressive, uncontrolled diseases of any organ system
- Abnormal laboratory tests or 12-lead ECG at screening as defined by protocol
- Pregnant or breastfeeding women
- Known allergy to study drug or its components
- History of alcohol abuse or illegal drug use within past year
- Receipt of live vaccine within 12 weeks before randomization or planned during study
- Blood donation of about 500 mL within 8 weeks before randomization or planned during study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chinese PLA General Hospital
Beijing, Beijing Municipality, China, 100039
Actively Recruiting
Research Team
L
Lihua Lin
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here